SAN DIEGO, CA — (Marketwired – October 19, 2016) – Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that it has garnered national news coverage in major local and national TV news outlets across the United States about the sweeping electoral victory for marijuana reform across the nation, including the passage of California’s Proposition 64, which legalized marijuana for recreational use in the state.
Chief Executive Officer of Medical Marijuana, Inc. Dr. Stuart Titus was interviewed on CW 6 News San Diego and National and local ABC affiliates, speaking about the social and medical benefits of legalizing both recreational and medical marijuana.
“The sweeping passage of cannabis reform across the country is a major win for the cannabis industry,” said Chief Executive Officer of Medical Marijuana, Inc. Dr. Stuart Titus. “The voters have spoken and they’ve made it clear that they are ready for cannabis reform, moving forward the newest multibillion-dollar industry in the U.S.”
In a historic night on U.S. election day Nov. 8, voters in California, Nevada, Maine and Massachusetts passed recreational use of marijuana in their respective states, while Florida, North Dakota, Montana, and Arkansas approved medical marijuana initiatives. The combined estimated legal marijuana markets for these states is a billion-dollar market this year, with the total market surpassing well over $40 billion by 2020.
About Medical Marijuana, Inc.
Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally-friendly, economically sustainable businesses, while increasing shareholder value. For details on Medical Marijuana, Inc.’s portfolio and investment companies, visit www.medicalmarijuanainc.com.
This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.
Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.
Public Relations Contact:
Chief Executive Officer
Corporate Business Contact:
Nicholas R. Massalas
Director of Business Development
Medical Marijuana, Inc.
OTC Symbol: MJNA
Toll Free: 888-OTC- MJNA (888-682- 6562)
Investor Relations Contact:
Toll Free: (877) 964.6463
Office/Direct: (858) 264-6500